Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

B-Complex: A Nutraceutical SANS Countermeasure

NCT05366933 is registered in ClinicalTrials.gov with National Aeronautics and Space Administration (NASA) as lead sponsor.

NCT NCT05366933
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05366933 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
B-Complex: A Nutraceutical SANS Countermeasure
Lead sponsor
National Aeronautics and Space Administration (NASA)
Phase
Phase 1
Overall status
Recruiting
Start date
August 1, 2022
Completion date
September 30, 2032
Enrollment
16 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endothelial dysfunction, optic disc edema